Clinical Trials Arena on MSN
FDA finalises psychedelic clinical trial guidance
The FDA is holding a public hearing to talk through psychedelic drug development on 14 September.
The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...
7d
Psychedelics guidance from the FDA set to benefit developers, including AtaiBeckley, Jefferies says
The US Food and Drug Administration's finalized guidance on psychedelic drug development signals the agency remains receptive ...
For years, the government and the public have been curious about the use of psychedelics for medicine. Beyond typical curiosity though, there have been real developments in recent years as to how to ...
Psychedelics: FDA offers clarifications, compromises in final clinical trial guidance FDA headquarters in Silver Spring, MD. (credit: Ferdous Al-Faruque) The US Food and Drug Administration (FDA) has ...
You can’t call it cheatin’, she reminds me of you,” the Gin Blossoms sang on their 1996 album Congratulations I’m Sorry. For sponsors ...
The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must do to seek approval of vaccines, a move that comes as the Trump ...
The FDA's draft guidance could streamline biosimilar approval by reducing the need for comparative efficacy studies, emphasizing analytical assessments instead. This approach may lower development ...
The FDA draft guidance recommends MRD and CR as endpoints for accelerated drug approval in multiple myeloma, emphasizing their role in indicating deep treatment response. MRD negativity is defined as ...
A coalition of public health organizations, pediatricians and parents has filed a federal lawsuit challenging the Food and Drug Administration's new enforcement policy that allows e-cigarette and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results